Oppenheimer Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.04M | Sell |
|
|||||
|
2025
Q1 | $8.47M | Sell |
|
|||||
|
2024
Q4 | $12.5M | Sell |
|
|||||
|
2024
Q3 | $12M | Sell |
|
|||||
|
2024
Q2 | $13.3M | Buy |
|
|||||
|
2024
Q1 | $15.2M | Sell |
|
|||||
|
2023
Q4 | $14.6M | Sell |
|
|||||
|
2023
Q3 | $15.9M | Sell |
|
|||||
|
2023
Q2 | $17.6M | Sell |
|
|||||
|
2023
Q1 | $16.3M | Buy |
|
|||||
|
2022
Q4 | $10.5M | Sell |
|
|||||
|
2022
Q3 | $11.4M | Sell |
|
|||||
|
2022
Q2 | $14.1M | Sell |
|
|||||
|
2022
Q1 | $19.9M | Sell |
|
|||||
|
2021
Q4 | $24.6M | Buy |
|
|||||
|
2021
Q3 | $22.2M | Sell |
|
|||||
|
2021
Q2 | $18.8M | Buy |
|
|||||
|
2021
Q1 | $14.5M | Buy |
|
|||||
|
2020
Q4 | $14.1M | Sell |
|
|||||
|
2020
Q3 | $14M | Sell |
|
|||||
|
2020
Q2 | $13.7M | Buy |
|
|||||
|
2020
Q1 | $8M | Buy |
|
|||||
|
2019
Q4 | $7.88M | Buy |
|
|||||
|
2019
Q3 | $7.31M | Sell |
|
|||||
|
2019
Q2 | $6.86M | Sell |
|
|||||
|
2019
Q1 | $6.1M | Buy |
|
|||||
|
2018
Q4 | $5.12M | Buy |
|
|||||
|
2018
Q3 | $6.43M | Buy |
|
|||||
|
2018
Q2 | $3.66M | Buy |
|
|||||
|
2018
Q1 | $3.07M | Sell |
|
|||||
|
2017
Q4 | $3.46M | Hold |
|
|||||
|
2017
Q3 | $3.46M | Buy |
|
|||||
|
2017
Q2 | $3.29M | Buy |
|
|||||
|
2017
Q1 | $952K | Buy |
|